Antitrust

Keller Rohrback L.L.P.’s antitrust and trade regulation practice represents individual and class plaintiffs in state and federal litigation. By litigating claims on behalf of businesses and consumers harmed by such practices, Keller Rohrback helps achieve the goal of the nation’s antitrust and trade regulation statutes, ensuring that consumers get the benefits of free and fair competition in the marketplace. Our clients include consumer and business class members who have been harmed by illegal, anti-competitive conduct. Keller Rohrback has substantial expertise in pursuing claims under the Sherman and Clayton Acts for price fixing, customer allocation, market division, exclusive dealing, price discrimination, the tying or bundling of products, misleading and deceptive marketing practices, monopolization and attempted monopolization of markets, and other related practices.

Keller Rohrback has played a prominent role in large price fixing, price discrimination and monopolization cases litigated across the country. We currently represent class members in various antitrust cases including cases alleging price fixing or monopolization against drug manufacturers, egg producers, potato growers, various categories of computer parts producers, railroad shippers, polychromatic lens manufacturers, the nation’s largest online DVD rental service, the world’s number one producer of computer chips, employers of agency nurses, hospital employers of nurses in various cities, and others. Recent achievements include: participation in the Vitamins Antitrust Litigation, which resulted in a partial settlement of approximately $1.1 billion; serving on the executive committee pursuing the Microsoft Antitrust Litigation where the class represented by Keller Rohrback was the only class of all those pursuing claims against Microsoft that actually received cash refunds for their overcharge rather than coupons; the infant formula price fixing litigation, producing a settlement of over $125 million; litigation against NASCAR that resulted in a settlement that allowed the Texas Motor Speedway to host a second NASCAR race worth hundreds of millions of dollars to shareholders; representing purchasers of Taq, an enzyme that plays a vital role in DNA diagnosis, testing and research, against Hoffman La-Roche and others resulting in a recovery of $33 million for scientists who have purchased Taq; and recovering significant sums (in cash) for Arizona government agencies (including school districts) who were overcharged for their Microsoft operating system software.